Cargando…
Parallel functional annotation of cancer-associated missense mutations in histone methyltransferases
Using exome sequencing for biomarker discovery and precision medicine requires connecting nucleotide-level variation with functional changes in encoded proteins. However, for functionally annotating the thousands of cancer-associated missense mutations, or variants of uncertain significance (VUS), p...
Autores principales: | Canning, Ashley J., Viggiano, Susan, Fernandez-Zapico, Martin E., Cosgrove, Michael S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630446/ https://www.ncbi.nlm.nih.gov/pubmed/36323913 http://dx.doi.org/10.1038/s41598-022-23229-2 |
Ejemplares similares
-
Loss-of-function mutations in the histone methyltransferase EZH2 promote chemotherapy resistance in AML
por: Kempf, Julia M., et al.
Publicado: (2021) -
A Saccharomyces cerevisiae model and screen to define the functional consequences of oncogenic histone missense mutations
por: Lemon, Laramie D, et al.
Publicado: (2022) -
Lysine Ethylation by Histone Lysine Methyltransferases
por: Al Temimi, Abbas H. K., et al.
Publicado: (2019) -
BRAF inhibition in melanoma is associated with the dysregulation of histone methylation and histone methyltransferases
por: Grigore, Florina, et al.
Publicado: (2020) -
CanDrA: Cancer-Specific Driver Missense Mutation Annotation with Optimized Features
por: Mao, Yong, et al.
Publicado: (2013)